104 related articles for article (PubMed ID: 15208652)
41. Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.
Musgrove EA; Davison EA; Ormandy CJ
J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):55-66. PubMed ID: 15082918
[TBL] [Abstract][Full Text] [Related]
42. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
Mixon M; Kittrell F; Medina D
Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
[TBL] [Abstract][Full Text] [Related]
43. p27kip1 contributions to cancer.
Nho RS; Sheaff RJ
Prog Cell Cycle Res; 2003; 5():249-59. PubMed ID: 14593719
[TBL] [Abstract][Full Text] [Related]
44. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
[TBL] [Abstract][Full Text] [Related]
45. Generation and analysis of Brca1 conditional knockout mice.
Deng CX; Xu X
Methods Mol Biol; 2004; 280():185-200. PubMed ID: 15187254
[TBL] [Abstract][Full Text] [Related]
46. Brca1 regulates in vitro differentiation of mammary epithelial cells.
Kubista M; Rosner M; Kubista E; Bernaschek G; Hengstschläger M
Oncogene; 2002 Jul; 21(31):4747-56. PubMed ID: 12101413
[TBL] [Abstract][Full Text] [Related]
47. Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes.
Campbell M; Aprelikova ON; van der Meer R; Woltjer RL; Yee CJ; Liu ET; Jensen RA
Cancer Gene Ther; 2001 Mar; 8(3):231-9. PubMed ID: 11332994
[TBL] [Abstract][Full Text] [Related]
48. The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis.
Díez-Juan A; Andrés V
FASEB J; 2001 Sep; 15(11):1989-95. PubMed ID: 11532979
[TBL] [Abstract][Full Text] [Related]
49. Protein expression profiling of primary mammary epithelial cells derived from MMTV-neu mice revealed that HER2/NEU-driven changes in protein expression are functionally clustered.
Park S; Lee KM; Ju JH; Kim J; Noh DY; Lee T; Shin I
IUBMB Life; 2010 Jan; 62(1):41-50. PubMed ID: 19960538
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical expression of p27 and p21 in canine cutaneous mast cell tumors and histiocytomas.
Wu H; Hayashi T; Inoue M
Vet Pathol; 2004 May; 41(3):296-9. PubMed ID: 15133184
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells.
Schlegel BP; Starita LM; Parvin JD
Oncogene; 2003 Feb; 22(7):983-91. PubMed ID: 12592385
[TBL] [Abstract][Full Text] [Related]
52. Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation.
Bai F; Smith MD; Chan HL; Pei XH
Oncogene; 2013 May; 32(22):2715-25. PubMed ID: 22777348
[TBL] [Abstract][Full Text] [Related]
53. Malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice.
Ellis FH; Xu X; Kulke MH; LoCicero J; Loda M
J Thorac Cardiovasc Surg; 2001 Oct; 122(4):809-14. PubMed ID: 11581618
[TBL] [Abstract][Full Text] [Related]
54. BRCA1 expression during prenatal development of the human mammary gland.
Magdinier F; Dalla Venezia N; Lenoir GM; Frappart L; Dante R
Oncogene; 1999 Jul; 18(27):4039-43. PubMed ID: 10435628
[TBL] [Abstract][Full Text] [Related]
55. Retroviral transduction of splice variant Brca1-Delta11 or mutant Brca1-W1777Stop causes mouse epithelial mammary atypical duct hyperplasia.
Bachelier R; Vincent A; Mathevet P; Magdinier F; Lenoir GM; Frappart L
Virchows Arch; 2002 Mar; 440(3):261-6. PubMed ID: 11889595
[TBL] [Abstract][Full Text] [Related]
56. The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.
Foulkes WD; Brunet JS; Stefansson IM; Straume O; Chappuis PO; Bégin LR; Hamel N; Goffin JR; Wong N; Trudel M; Kapusta L; Porter P; Akslen LA
Cancer Res; 2004 Feb; 64(3):830-5. PubMed ID: 14871808
[TBL] [Abstract][Full Text] [Related]
57. Switching of melanocyte pigmentation associated with pituitary pars intermedia tumors in Rb+/- and p27-/- female mice with yellow pelage.
Smith AP; Henze M; Osborn KG; Lee JA; Bortner DM; Rosenberg MP; Reed SI
Comp Med; 2003 Feb; 53(1):75-80. PubMed ID: 12625510
[TBL] [Abstract][Full Text] [Related]
58. Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice.
Rantakari P; Nikkilä J; Jokela H; Ola R; Pylkäs K; Lagerbohm H; Sainio K; Poutanen M; Winqvist R
Hum Mol Genet; 2010 Aug; 19(15):3021-9. PubMed ID: 20484223
[TBL] [Abstract][Full Text] [Related]
59. Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells.
You F; Chiba N; Ishioka C; Parvin JD
Oncogene; 2004 Jul; 23(34):5792-8. PubMed ID: 15122325
[TBL] [Abstract][Full Text] [Related]
60. Effect of corticosterone administration on mammary gland development and p27 expression and their relationship to the effects of energy restriction on mammary carcinogenesis.
Zhu Z; Jiang W; Thompson HJ
Carcinogenesis; 1998 Dec; 19(12):2101-6. PubMed ID: 9886563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
